AngioDynamics: Fiscal Second Quarter Earnings Overview

AngioDynamics Reports Second Quarter Financial Results

AngioDynamics Inc., headquartered in Latham, New York, announced a net loss of $6.4 million for its fiscal second quarter.

The company reported a loss of $0.15 per share. After adjusting for expenses related to mergers, acquisitions, and amortization, the adjusted loss per share was less than one cent.

During this quarter, the medical technology firm generated $79.4 million in revenue.

Looking ahead, AngioDynamics projects its annual performance will result in a loss between $0.33 and $0.23 per share, with anticipated revenue falling between $312 million and $314 million.

Since the start of the year, AngioDynamics' stock price has increased by 3%, and over the past year, shares have gained 46% in value.

Report generated by Automated Insights using data from Zacks Investment Research.